article · Nigerian Postgraduate Medical Journal
BACKGROUND: Percutaneous liver biopsy (PLB) is a procedure through which liver tissue is obtained for making the diagnosis of liver diseases. Most PLBs are performed as a day case procedure, and complications can occur. OBJECTIVE: This study assessed the safety of PLBs as a day case procedure. METHODS: A cross-sectional descriptive study of participants aged 18 years and above who had a day case PLB from January 2021 to June 2024. Standard precautions were observed, and eligible participants after the procedure were observed for 4-6 h. Post-biopsy complications were looked for and their time duration was recorded. Data obtained were collated and entered into SPSS version 20 and analysed using simple and inferential statistics. A P < 0.05 was considered statistically significant. RESULTS: There were 125 participants comprising 71 (56.8%) females and 54 (43.2%) males, with an age range of 18-70 years, with a mean ± standard deviation (SD) of 44.4 (13.0) years. A total of 161 complications amongst 101 (80.8%) participants occurred, with some participants having two or more complications. The most common were pain at the shoulder tip, 41 (32.8%) and pain at the biopsy site, 93 (74.5%), with mean ± (SD) time duration of 58.9 (47.3) and 96.6 (71.7) min, respectively. Participants with metabolic dysfunction-associated steatotic liver disease, those aged > 40 years and participants with echogenic liver on ultrasound had more post-biopsy complications than others, P < 0.05. There was no death or post-biopsy admission. CONCLUSIONS: Day case PLB is safe, and the most common complications are pain at the shoulder tip and biopsy site.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/npmj.npmj_324_25
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.